The company has signed agreements with MilliporeSigma to scale manufacturing and with Hamilton Company to market a turnkey solution to help CLIA laboratories rapidly add testing capacity.
Read More
This investment will enable Hologic to expand production capacity to 13 million covid-19 tests per month by January 2022.
Read More
Under this agreement, the New River Health District secures access to TechLab’s analyte-specific reagents for SARS-CoV-2 for as little as $7 to $9 per use.
Read More
Engineered recombinant antibodies offer advantages over serum-based controls.
Read More
In a letter to clinical lab staff and healthcare providers, FDA offers recommendations for the proper use of antigen tests for covid-19.
Read More